0001179110-20-000889.txt : 20200130
0001179110-20-000889.hdr.sgml : 20200130
20200130172349
ACCESSION NUMBER: 0001179110-20-000889
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200128
FILED AS OF DATE: 20200130
DATE AS OF CHANGE: 20200130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YOOR BRIAN B
CENTRAL INDEX KEY: 0001643528
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 20562383
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: AP6A-2, D-032L
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
edgar.xml
FORM 4 -
X0306
4
2020-01-28
0
0000001800
ABBOTT LABORATORIES
ABT
0001643528
YOOR BRIAN B
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064-6400
0
1
0
0
Executive Vice President & CFO
Common shares without par value
2020-01-28
4
M
0
41229
47
A
155610
D
Common shares without par value
2020-01-28
4
M
0
81709
48.90
A
237319
D
Common shares without par value
2020-01-28
4
M
0
213470
38.40
A
450789
D
Common shares without par value
2020-01-28
4
M
0
91121
44.40
A
541910
D
Common shares without par value
2020-01-28
4
M
0
82321
59.94
A
624231
D
Common shares without par value
2020-01-28
4
S
0
509850
89.7268
D
114381
D
Common shares without par value
2239
I
Profit Sharing Trust
Option (right to buy)
47.00
2020-01-28
4
M
0
41229
0
D
2018-02-20
2025-02-19
Common shares
41229
0
D
Option (right to buy)
48.90
2020-01-28
4
M
0
81709
0
D
2018-06-01
2025-05-31
Common shares
81709
0
D
Option (right to buy)
38.40
2020-01-28
4
M
0
213470
0
D
2019-02-19
2026-02-18
Common shares
213470
0
D
Option (right to buy)
44.40
2020-01-28
4
M
0
91121
0
D
2019-02-17
2027-02-16
Common shares
91121
45561
D
Option (right to buy)
59.94
2020-01-28
4
M
0
82321
0
D
2019-02-16
2028-02-15
Common shares
82321
164642
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.57 to $89.87, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Balance in the Abbott Laboratories Stock Retirement Trust as of January 28, 2020.
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
Jessica H. Paik, by power of attorney for Brian B. Yoor
2020-01-30